ADTX (Aditxt Inc.) Bozor qiymatining balans qiymatiga nisbati
Aditxt (ADTX) uchun asosiy xavf biotexnologiya aktivlarining agressiv sotib olinishi natijasida yuzaga kelgan likvidlik tanqisligi bo'lib qolmoqda. Biroq, o'sish potentsiali transplantatsiya uchun noyob immunitet nazorati usullari hamda diagnostika va autoimmun patologiyalar terapiyasi o'rtasidagi sinergizm bilan belgilanadi. Bozor kapitalizatsiyasining balans qiymatiga nisbati o'zgarishi tayanch darajasini namoyish etmoqda, bunda ko'rsatkich 0.00 atrofida saqlanib qolgan bo'lib, bu aktivning haddan tashqari qiziganlik darajasini baholashga yordam beradi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_ADTX_-_Aditxt_-_Market-Capitalization-to-Net-Assets "ADTX Aditxt, Inc. Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 11.07.2026) | 👁️GURU.Markets👁️")
Aditxt (ADTX) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:Aditxt Inc. - ADTX
Investorlar Aditxt (ADTX) kompaniyasining salohiyatini uning aktivlariga bo'lgan bozor ishonchi prizmasi orqali bahlamoqdalar. Ushbu koeffitsient biznesning joriy bozor qiymatini uning sof balans qiymati bilan solishtirib, kapital haddan tashqari qimmat yoki arzon baholanganini aniqlaydi. Joriy narx-kitob koeffitsiyentini tahlil qilish spekulyativ narxlarning keskin ko'tarilishini filtrlashga yordam beradi. Immunitetni monitoring qilish tizimlari provayderi bo'lgan ushbu kompaniya uchun mazkur metrika uning texnologik bazasining real qiymatini aks ettiradi. Aktiv yuqori xavfli tibbiy ishlanmalar toifasiga kiradi.
Asosiy raqobatchilar
Kapitallashuvning sof aktivlarga nisbati argenx SE|BNTX (biontech.de) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Astria Therapeutics|engene.com (ENGN) - Kapitallashuvning balans qiymatiga nisbati|RAPT: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Aerovate (JBIO)|Kapitallashuvning sof aktivlarga nisbati Aclaris|Bozor kapitallashuvining balans qiymatiga multiplikatori Kyverna Therapeutics, Inc KYTX|TLSA - Kapitallashuvning sof aktivlarga nisbati|CABA - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ventyx Biosciences, Inc. VTYX|THTX - Bozor kapitallashuvining balans qiymatiga multiplikatori|AVTX: Bozor kapitallashuvining balans qiymatiga nisbati|Eledon Pharmaceuticals, Inc (ELDN) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Agenus (AGEN)|Kapitallashuvning balans qiymatiga nisbati climbbio.com (CLYM)|Kapitallashuvning sof aktivlarga nisbati Zura Bio|Bozor kapitallashuvining balans qiymatiga multiplikatori aTyr Pharma Inc ATYR|ADAG - Kapitallashuvning sof aktivlarga nisbati|ImageneBio - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Shattuck Therapeutics|EQ - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati connectbiopharm.com CNTB|Immunic (IMUX) - Balans qiymatiga nisbatan bozor qiymati|ATRA (Atara Biotherapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IFRX|X4 Pharmaceuticals (XFOR) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ACET (adicetbio.com)|Celularity - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati INmune Bio Inc INMB|Barinthus Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Kezar Life Sciences Inc (KZR) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati SAB Biotherapeutics SABS|akaritx.com (AKTX) - Balans qiymatiga nisbatan bozor qiymati|ENLV: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi QTTB|Bozor qiymatining balans qiymatiga nisbati GOVX (GeoVax Labs Inc)|Kapitallashuvning sof aktivlarga nisbati EDSA (Edesa Biotech Corp)|iBio, Inc. - Bozor qiymatining balans qiymatiga nisbati|CARM - Kapitallashuvning sof aktivlarga nisbati|XTL Biopharmaceuticals Ltd. - Kapitallashuvning sof aktivlarga nisbati|BOLT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati hcwbiologics.com|Aptevo Therapeutics Inc. (APVO) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AIM (AIM ImmunoTech Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti gribio.com|Bozor kapitallashuvining balans qiymatiga nisbati XRTX|Bozor kapitallashuvining balans qiymatiga nisbati Vyome Holdings Inc. (HIND)|REVB - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Indaptus Corp INDP|Bozor kapitallashuvining balans qiymatiga nisbati SCNI (Scinai Immunotherapeutics)|CalciMedica, Inc. (CALI) - Balans qiymatiga nisbatan bozor kapitallashuvi|AFMD - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Allakos|Kapitallashuvning sof aktivlarga nisbati HOOKIPA Pharma, Inc. (HOOK)|Kapitallashuvning balans qiymatiga nisbati IGM Bio (IGMS)|Kapitallashuvning sof aktivlarga nisbati iTeos Therapeutics|Bozor kapitallashuvining balans qiymatiga multiplikatori oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD